Dangerous Drug: Tenecteplase



Dangerous Drug: Tenecteplase





(teh nek’ ti plaze)

TNKase

PREGNANCY CATEGORY C


Drug class

Thrombolytic enzyme


Therapeutic Actions

Enzyme that converts plasminogen to the enzyme plasmin (fibrinolysin), which degrades fibrin clots; lyses thrombi and emboli; is most active at the site of the clot and causes little systemic fibrinolysis.


Indications



  • Reduction of mortality associated with acute MI



Available Forms

Powder for injection—50 mg


Dosages

Adults

Warning Do not exceed 50 mg/dose. Initiate treatment as soon as possible after onset of acute MI. Administer as IV bolus over 5 sec. Dose is based on weight:

Less than 60 kg: 30 mg IV.

60–69 kg: 35 mg IV.

70–79 kg: 40 mg IV.

80–89 kg: 45 mg IV.

90 kg or more: 50 mg IV.

Pediatric patients

Safety and efficacy not established.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jul 21, 2016 | Posted by in NURSING | Comments Off on Dangerous Drug: Tenecteplase

Full access? Get Clinical Tree

Get Clinical Tree app for offline access